Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art

3 Nov 2022

Abstract excerpt

There is considerable interindividual variability in the response to antiplatelet and anticoagulant therapies, and this variation may be attributable to genetic variants. There has been an increased understanding of the genetic architecture of stroke and cardiovascular disease, which has been driven by advancements in genomic technologies and this has raised the possibility of more targeted pharmaceutical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiplatelet Therapy and Cardiovascular Diseases
Share to Lipoproteins and Cardiovascular Health
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36325912
DOI: 10.1161/strokeaha.122.037717

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics in Stroke and Cardiovascular Disease: State of the ArtPMID 36325912Read ↗

Pharmacogenetics and stroke.Semantic proximity Read ↗

The Role of Pharmacogenetics in Antithrombotic Therapy Management: New Achievements and Barriers Yet to OvercomeSemantic proximity Read ↗

Use of genetic data to guide therapy in arterial disease.Semantic proximity Read ↗

Genetics of Ischemic Stroke, Stroke-Related Risk Factors, Stroke Precursors and TreatmentsSemantic proximity Read ↗

Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx).Semantic proximity Read ↗

Use of Pharmacogenetic Information in the Treatment of Cardiovascular Disease.Semantic proximity Read ↗

Stroke genetics: prospects for personalized medicine.Semantic proximity Read ↗

The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence.Semantic proximity Read ↗

Genetic signatures in the treatment of stroke.Semantic proximity Read ↗

Genotype-guided dual antiplatelet therapy in cerebrovascular disease: assessing the risk and benefits for ethnic populations.Semantic proximity Read ↗

Pharmacogenetics and cardiovascular disease--implications for personalized medicine.Semantic proximity Read ↗

Genetic susceptibility to ischemic stroke.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.